Instructions for Integrated Care Pathway use

Size: px
Start display at page:

Download "Instructions for Integrated Care Pathway use"

Transcription

1 αβχ Instructions for Integrated Care Pathway use This pathway is to be used in place of all previous documentation for patients with a Deep Vein Thrombosis (DVT). It is to be used by Emergency Department doctors and Anticoagulant Nurse Practitioner(s) to assess and treat (see relevant PGDs) outpatients with a proven DVT. It is a legal document, therefore all entries on the pathway, must be signed for with the date and time of entry Where possible the pathway has been based on clinical evidence. Where no evidence is available, a decision has been made to use best clinical practise. The pathway is a prompt only, any deviations from the pathway, must be written into the pathway along with any action taken and the results of the action. The variance must also be signed. This process enables the practitioner to use their clinical judgement and also enables the pathway to be audited more easily. The pathway follows the patient throughout their treatment. To use the pathway, just follow the prompts, fill in the relevant spaces, add any variances and then sign at the bottom of the sheet, to indicate that you have completed the pathway of care. Abbreviations used: Appt = Appointment MAU = Medical admissions unit B.P. = Blood pressure Min = Minute D.V.T = Deep Vein Thrombosis 02 = Oxygen E.D = Emergency Department P.E = Pulmonary embolism e.g. = for example POP = Plaster of Paris G.P. = General Practitioner Pt = Patient G.I. = Gastro Intestinal Resps = Respiration Hb = Haemoglobin S/C = Subcutaneous ICP = Integrated Care Pathway S.O.B = Short of Breath IU = International Units Tel no = Telephone Number INR = International Normalised USS = Ultra sound scan Ratio -ve = negative Kg = Kilograms +ve = positive l = litres V.A.U = Vascular assessment unit LMWH = Low Molecular Weight Heparin If you have any problems with this pathway. Please contact Elaine Willman ext 4442, or Liz Murray - Anticoagulant Nurse Specialist ext 4006 C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04

2 αβχ Attach Patient Label Here D.V.T. Pathway Hospital Number Radiologist Written Report (please affix printed sheet or hand write report) If a positive DVT, is the Arterial Wave form at the ankle triphasic / biphasic / monophasic? C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 2 Nov04

3 Dr or Nurse Practitioner follow steps 1-6 Nurse Discharging Patient follow step 7 Treat ALL occlusive DVT s with anticoagulation. Non occlusive below knee DVT s need Aspirin and a repeat scan in 10 days (if already taking Aspirin please discuss with E.D. Senior) Step 1. Ensure patient has had LFT s. FBC, INR and U&E s taken and sent to the lab Step 2. Is the patient suitable for Out Patient treatment? All answers must be No to proceed to Out Patient Treatment REASONS FOR ADMISSION Yes No Suspected / confirmed Pulmonary emboli Significant swelling above knee, suggestive of iliac thrombus or vena cava thrombus Active bleeding e.g. intracranial bleed within the last 6 months, G.I. bleed within 1 month, oesophageal varices, macroscopic haematuria within 1 month Verified bleeding disorders e.g. haemophilia, platelets <100 Renal failure with serum creatinine >300mmols/ltre History of hypersensitivity to heparin, heparin induced thrombocytopenia, heparin induced thrombosis Baseline INR >1.4 or / and abnormal LFT s Other evidence of chronic Liver Disease Pregnant patients - refer to Haematologist Likelihood of non-compliance e.g. dementia, drug addiction, unable to self medicate safely C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04

4 αβχ Attach Patient Label Here D.V.T. Pathway Hospital Number Step 3 Presenting complaint: SOB? Chest Pain? Past Medical History: Medication: Allergies: Systemic Enquiry: Yes/ No Social History: Unexplained weight loss Anorexia Night Sweats Bowel Habit note changes Urinary problems Post menopausal bleeding If suspect occult carcinoma arrange urgent follow up OPA 2/52 OBSERVATIONS Thigh Measurement: Right Left Temp oc Calf Measurement: Right Left Pulse B.P. Affected Leg: Resps 02 Sats Pain Heat Weight Kgs Other examination findings: C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 4 Nov04

5 Sign /Status/ Date & time: Step 4 Document blood results here. If abnormal discuss with Senior Dr before prescribing Warfarin Blood results: Hb g/dl Creatinine mol/l WBC x10/l INR Platelets x10/l LFT s Urea mmol/l D.Dimer Recommendations for Anticoagulant Treatment DVT Length of treatment Therapeutic Range Post op calf 6weeks Spontaneous calf 3 months Proximal 6 months Recurrent (not taking warfarin)? long term(consider thrombophilia screen) Recurrent (taking warfarin) Long term (refer to physicians) Taken from Guidelines on Oral Anticoagulation prepared by the Haemostasis and Thrombosis Task force Reference BJH, 1998,101, Anticoagulant Nurse Practitioner to supply prescription against Patient Group Direction or E.D Dr to write prescription for 28 x 1mg Warfarin tablets 28 x 3mg Warfarin tablets Dalteparin (dose according to weight) S/C OD for 5 days. (Pre-labelled boxes of these drugs are stocked in SSEU drug cupboard) Give patient yellow anticoagulation book with written instructions for loading dose of warfarin (normally 10mg, 10mg & 5mg of warfarin over 3 days). Warfarin should only be started on Mondays, Tuesdays & Fridays to tie in with Anticoagulation Clinic for 1 st INR. Patient to attend Anticoagulation Clinic in Pathology Reception between 9am & 10am on 4 th day of warfarin treatment (do not need appointment but will need to bring yellow anticoagulation book with them) & to ask to see Anticoagulation Nurse. Dalteparin Doses USE ONLY FIXED DOSE PRE-FILLED SYRINGES Weight Dose < 46Kg 7,500iu 46-56kg 10,000iu 57-68kg 12,500iu 69-82kg 15,000iu >83kg 18,000iu C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04

6 Step 5 Dr to complete Anticoagulant Service Referral Form Patient Details: Hospital no. Surname Previous surname Date of birth Post Code Referral Details: Referring clinician GP Practice/ Ward / Clinic Date of referral Date of consultation Dear Doctor / Nurse Practitioner NHS no. Forenames Title Home tel. no. Work tel. no. Mobile no. Sex Preferred clinician (if applicable) New referral? Yes Rereferral? Date last seen Dates not available The above patient requires anticoagulation with warfarin for treatment of (please tick): Deep vein thrombosis Prophylaxis of DVT Pulmonary embolism Myocardial infarction Recurrent DVT/PE Transient ischaemic attack Prosthetic heart valve CABG Atrial fibrillation Arterial disease Other (please describe) Proposed duration of treatment is: 3 months 6 months 12 months Long term Other Desired therapeutic range: INR INR Other Treatment of DVT and PE Systemic embolism Prevention of venous thromboembolism after MI Mitral stenosis with embolism AF Transient ischaemic attacks Xenograft or homograft heart valve replacements ( for Carbomedics valve replacements) Does patient have? Liver disease/alcoholism Malabsorption Renal failure Please list all concomitant medication Recurrent DVT and PE Mechanical prosthetic heart valves Arterial disease including MI Cardiac failure Peptic ulcer Mental impairment Should patient stop any medication before starting warfarin?. Has patient started warfarin?* Yes/ No Date prescription issued (the referring doctor must supply all patients with a prescription of warfarin) For non-urgent warfarinisation it is preferable to allow the clinic to commence warfarin, so that blood tests can be co-ordinated with clinic days. * If yes, please state doses already given (for patients being discharged from hospital, please ensure that inpatient anticoagulant record accompanies this form): Date INR Dose Date INR Dose Date INR Dose Date INR Dose No Signed Date C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 6 Nov04

7 For further assistance please contact the anticoagulant nurse or Dr Jonathan Cullis ext 4828 C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04

8 Step 6 assessing Dr must complete this and send to GP αβχ DOB (or affix patient label) Emergency Department/ Short Stay Emergency Unit Date: / / GP details:.. PATIENT DISCHARGE SUMMARY Deep Vein thrombosis Dear Dr Your patient attended the Emergency Department and was diagnosed with the following:- Above knee DVT Occlusive DVT Diagnosis Below knee DVT Non occlusive DVT Treatment Your patient has/ has not commenced anticoagulation treatment Predisposing factors:- As no cause for the patient s DVT has been identified please would you ensure that your patient has a general health screen within the next month. Waveform from Duplex scan is Monophasic please do not prescribe compression hosiery Biphasic / Triphasic please prescribe compression hosiery Your patient has / has not been referred to the physicians for follow up If your patient requires a Thrombophilia screen, this will be arranged by the anticoagulant clinic at the end of anticoagulation treatment Additional Comments Thank you Signed Designation Please give a copy of the letter to the patient C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 8 Nov04

9 αβχ Attach Patient Label Here D.V.T. Pathway Hospital Number Step 7 Nurse to complete the following discharge procedure Subject Discuss diagnosis with patient / relatives and give patient information leaflet. Comments Does patient need additional social care? Medications given to patient Yes / No Patient aware of need to obtain Compression Stockings from G.P. /Community Nurse Comments: Patient taught to self administer Dalteparin Relative / carer taught to administer Dalteparin Referral to District Nurse /Practise nurse for daily Dalteparin Community Nurse letter completed and given to the patient Patient given sharps bin and instruction for use Yes / No Yes / No Yes / No Yes / No Yes / No Dalteparin Record of Administration Dalteparin S/C Dose Given by Batch Number Date Time Site of injection VARIANCE RECORDING SHEET DATE TIME VARIANCE/ REASON ACTION TAKEN AND RESULT FROM ACTION SIGN C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04

10 αβχ Date / / Community Nurse DISCHARGE SUMMARY Deep Vein thrombosis Anticoagualtion Service DOB Salisbury District Hospital Salisbury Wiltshire SP2 8BJ (or affix patient label) Tel GP Dear Community Nurse/Practice Nurse The above patient has been diagnosed with a DVT and has commenced Anticoagulation treatment with Dalteparin and Warfarin. As the patient is unable to self-inject could you please ensure that the Dalteparin is given as per the following instructions: Day, Date & Time Dose of Dalteparin Injection site Batch No Exp date Given by The patient is due to start Warfarin as follows: Day & Date Dose of Warfarin to be 6pm The patient needs to have their first INR taken on.. and have been given an appointment to attend the Anticoagulant Clinic at Salisbury District Hospital. The patient needs to have their first INR taken on.. but is unable to attend the Anticoagulant Clinic at Salisbury District Hospital. Please would you could take the INR in the community and send it to us. Many thanks for your assistance. Drs Signature Date and time Note for the Patient: If you have not heard from the community nurse by 5pm on the day that you are expecting your injection, please phone either of the following numbers and speak to someone who can help you to contact the community nurse. The numbers are: Twilight Nurses (mobile ) or Hants patients ext 6308, Dorset ext 6305 C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 10 Nov04

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust Venous. Thromboembolism (VTE) Assessment and Management

The Newcastle upon Tyne Hospitals NHS Foundation Trust Venous. Thromboembolism (VTE) Assessment and Management The Newcastle upon Tyne Hospitals NHS Foundation Trust Venous Thromboembolism (VTE) Assessment and Management Version No: 2.0 Effective From: 16 April 2018 Expiry Date: 16 April 2021 Date Ratified: 23

More information

Cyclophosphamide INFUSION Infusion 4 Plus

Cyclophosphamide INFUSION Infusion 4 Plus Cyclophosphamide Infusion Day DEPARTMENT OF RHEUMATOLOGY DAY CASE ADMISSION RECORD PATIENT DAY CASE BOOKING REQUEST To be completed by Consultant, Registrar requesting day case Admission Hospital No. Forename

More information

Are you at risk of blood clots?

Are you at risk of blood clots? Are you at risk of blood clots? DVT (deep vein thrombosis) & PE (pulmonary embolism) Information for patients in hospital or going home from hospital Are you at risk of blood clots? (DVT & PE) This leaflet

More information

Case Presentation. Cindy Felty MSN, RN, CNP, FCCWS Assistant Professor of Medicine Mayo Clinic March 27, 2008

Case Presentation. Cindy Felty MSN, RN, CNP, FCCWS Assistant Professor of Medicine Mayo Clinic March 27, 2008 Case Presentation Cindy Felty MSN, RN, CNP, FCCWS Assistant Professor of Medicine Mayo Clinic March 27, 2008 Acute DVT Case 1- Day 1 68 year old male admitted overnight to hospital for painful acute DVT

More information

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment

More information

University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE)

University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE) University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE) Information for adult inpatients and for patients due to be admitted If you need a large print, audio, braille, easy read

More information

Blood clot prevention. A guide for patients and carers

Blood clot prevention. A guide for patients and carers Blood clot prevention A guide for patients and carers Contents Introduction 1 What is a venous thromboembolism (VTE)? 1 What is a deep vein thrombosis (also known as a DVT)? 1 What is a pulmonary embolism

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Venous Thrombo-Embolism Policy YELLOW - Clinical New or

More information

Venous Thromboprophylaxis (VTE) Policy

Venous Thromboprophylaxis (VTE) Policy Venous Thromboprophylaxis (VTE) Policy Document Summary The intention of this policy is to ensure that all adult patients and service users of Cumbria Partnership Foundation NHS Trust are assessed for

More information

Sheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines

Sheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines Sheffield Teaching Hospitals: Pulmonary Hypertension Information for Medical Staff 31/03/2014 Local guidelines Diagnostic pathway - page 2 Iloprost dosing chart and conversion table - page 3-4 Hickman

More information

KEY TO INITIALS OF ALL STAFF COMPLETING THIS ICP Print name Designation Initials Signature date

KEY TO INITIALS OF ALL STAFF COMPLETING THIS ICP Print name Designation Initials Signature date Forename Surname Unit number Address (including Postcode) NHS Lothian Arrived in.unit for procedure Date: & time: GP Address Religion Ethnic Origin Tel. number Next of Kin: /address Tel. number(s):home

More information

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION Apixaban ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION 1 WHAT DOES APIXABAN (ELIQUIS ) DO? blood thinner Prevents or treats blood clots This is how a blood clot might look inside a blood

More information

East Lancashire DVT Local Enhanced Services (LES)

East Lancashire DVT Local Enhanced Services (LES) Agenda Item No: 6.5 REPORT TO: PRIMARY CARE COMMITTEE MEETING DATE: 13 September 2017 REPORT TITLE: SUMMARY OF REPORT: REPORT RECOMMENDATIONS: East Lancashire DVT Local Enhanced Services (LES) The paper

More information

Statement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process.

Statement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process. THROMBOSIS GROUP Venous thromboembolism (VTE) is a collective term referring to deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is defined by the following ICD-10 codes: I80.0-I80.3, I80.8-I80.9,

More information

Best Practice Guidelines - BPG 7 VTE (Venous Thrombo Embolism)

Best Practice Guidelines - BPG 7 VTE (Venous Thrombo Embolism) Best Practice Guidelines - BPG 7 VTE (Venous Thrombo Embolism) (Venous Thrombo Embolism) 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT

More information

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Protocol Number: 7 Protocol Title: Ambulatory Initiation and Management of Warfarin for Adults Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Target Patient

More information

Clinical Policies Group notified to Quality and Safety Operational Group Approval Date 31/05/2017 Initial Equality Impact Screening

Clinical Policies Group notified to Quality and Safety Operational Group Approval Date 31/05/2017 Initial Equality Impact Screening Document Details Title Reducing the Risk of Venous Thromboembolism Policy Trust Ref No 1544-36862 Local Ref (optional) NA This policy is intended to support clinical staff at Shropshire Main points the

More information

Patient Sticker Blood Transfusion Ambulatory Emergency Care Pathway

Patient Sticker Blood Transfusion Ambulatory Emergency Care Pathway Patient Sticker Blood Transfusion Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open:

More information

Deep Vein Thrombosis (DVT) - Blood Clots

Deep Vein Thrombosis (DVT) - Blood Clots Patient information Deep Vein Thrombosis (DVT) - Blood Clots i Important information for all patients. Golden Jubilee National Hospital Agamemnon Street Clydebank, G81 4DY (: 0141 951 5000 www.nhsgoldenjubilee.co.uk

More information

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION Rivaroxaban ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION 1 WHAT DOES RIVAROXABAN (XARELTO ) DO? blood thinner Prevents or treats blood clots This is how a blood clot might look inside

More information

Preventing hospital-acquired blood clots

Preventing hospital-acquired blood clots Preventing hospital-acquired blood clots Haematology Department Patient information leaflet This leaflet explains more about blood clots, which can form after illness and surgery. What are hospital-acquired

More information

CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage

CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage Suspected Non Variceal upper GI haemorrhage If any features suggest liver disease consult the variceal haemorrhage guideline http://www.rcht.nhs.uk/documentslibrary/royalcornw

More information

Venous Thromboembolism Policy

Venous Thromboembolism Policy Venous Thromboembolism Policy Name of Policy Authors Dr Liz Grey-Davies, Consultant Haematologist and Titles: Julianne Rigby, VTE Prevention nurse Dr Christopher Tibbs, Medical Director Miss Renata Hutt,

More information

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly

More information

STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists. Issued by: Contact:

STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists. Issued by: Contact: STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists Standing Order used for the Community Pharmacy Anticoagulant Management (CPAM) Service

More information

An Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015

An Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015 An Evaluation of the BVH Initiation of warfarin for DVT Sean O Brien Specialist Anticoagulation BMS Oct 2015 Service Provision ADAS is a Consultant led service managed by the Pathology Directorate. Provides

More information

POLICY FOR the Assessment, Prevention and Treatment of Venous Thrombo-Embolism. Policy Reference: Version: 1 Status: Approved

POLICY FOR the Assessment, Prevention and Treatment of Venous Thrombo-Embolism. Policy Reference: Version: 1 Status: Approved POLICY FOR the Assessment, Prevention and Treatment of Venous Thrombo-Embolism Policy Reference: Version: 1 Status: Approved Type: Clinical Policy applies to : All SCH staff within relevant groups; community

More information

Accreditation Program: Long Term Care

Accreditation Program: Long Term Care ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission

More information

CarePartners Nursing Care Plan Anticoagulant Therapy

CarePartners Nursing Care Plan Anticoagulant Therapy CarePartners Nursing Care Plan Anticoagulant Therapy ** If a CarePartners wound pathway, palliative care plan or oncology care plan is being used to guide the patient s care, this Nursing Care Plan may

More information

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service ANTICOAGULATION MONITORING SERVICE Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service Version: Date at ET/PEC: September 2008 Date ratified at Board: Name and

More information

Prevention and Treatment of Venous Thromboembolism (VTE) Policy

Prevention and Treatment of Venous Thromboembolism (VTE) Policy CONTROLLED DOCUMENT Prevention and Treatment of Venous Thromboembolism (VTE) Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled

More information

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire

More information

Inguinal hernia repair integrated care pathway (ICP)

Inguinal hernia repair integrated care pathway (ICP) Name Ward Hosp no DOB Affix patient label Inguinal hernia repair integrated care pathway (ICP) Inclusion criteria Patients undergoing inguinal hernia repair aged under 3 months corrected gestational age

More information

OPAT CELLULITIS PATHWAY

OPAT CELLULITIS PATHWAY OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES

More information

Policy for Venous Thromboembolism Prevention and Treatment

Policy for Venous Thromboembolism Prevention and Treatment Policy for Venous Thromboembolism Prevention and Treatment Start date: May 2013 Next Review: May 2015 Committee approval: Endorsed by: Distribution: Location Thrombosis and Thromboprophylaxis Steering

More information

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural

More information

ANTI-COAGULATION MONITORING

ANTI-COAGULATION MONITORING ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This

More information

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION Dabigatran ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION 1 WHAT DOES DABIGATRAN (PRADAXA ) DO? blood thinner Prevents or treats blood clots This is how a blood clot might look inside

More information

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL Community Clinics Policy and Procedure Manual C - 9 SUBJECT: WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL APPROVED BY: VP Acute & Long Term Care & COO (South) EFFECTIVE DATE: 2007

More information

Indian River Medical Center Policy #: 10.1 Policies and Procedures

Indian River Medical Center Policy #: 10.1 Policies and Procedures Indian River Medical Center Policy #: 10.1 Policies and Procedures Title: ANTICOAGULATION CLINIC Effective Date: Chapter: Pharmacy Reviewed Date: Responsible Person: Director of Pharmacy Revised Date:

More information

Drug Therapy Management

Drug Therapy Management 4/17 Welcome to the Centers of Excellence Assessment Becoming an Anticoagulation Center of Excellence gives your service the chance to work as a multidisciplinary team to evaluate your current safety practices

More information

PROTOCOL FOR VENESECTION

PROTOCOL FOR VENESECTION PROTOCOL FOR VENESECTION Author: Scope: Date: Dr John de Vos All staff who carry out venesection June 2015 (original June 2006 Dr Janet Shirley) Ratified by: Clinical Audit and Effectiveness Committee

More information

Patient Diary. Enhanced Recovery After Surgery (ERAS) Total Knee Replacement. Helping patients get better sooner after surgery.

Patient Diary. Enhanced Recovery After Surgery (ERAS) Total Knee Replacement. Helping patients get better sooner after surgery. Contact numbers If you need any support or advice before or after surgery please do not hesitate to call us. Claire Ward enhanced recovery nurse (Monday Friday 8-4) 07816448518 Ward 12B 01494426398 How

More information

Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants

Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Trust Policy Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Purpose Date Version March 2015 2 To manage the inherent risks to patients from the use

More information

Setting up the NOAC Service & Taking it to Primary Care

Setting up the NOAC Service & Taking it to Primary Care Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side

More information

Venous Thromboembolism (VTE) Prevention and Management Policy and Procedures

Venous Thromboembolism (VTE) Prevention and Management Policy and Procedures PLEASE NOTE: Whilst the review date for this policy has passed, it is still the current version that should be used by staff. Director of Nursing and Medical Director, April 2014 Venous Thromboembolism

More information

Patient Sticker Syncope Ambulatory Emergency Care Pathway

Patient Sticker Syncope Ambulatory Emergency Care Pathway Patient Sticker Syncope Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open: Monday

More information

Patient Sticker Paracentesis Ambulatory Emergency Care Pathway

Patient Sticker Paracentesis Ambulatory Emergency Care Pathway Patient Sticker Paracentesis Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open:

More information

After reading this learning module, the nurse should be able to:

After reading this learning module, the nurse should be able to: After reading this learning module, the nurse should be able to: Identify the VTE dashboard and understand how to initiate it Identify the requirements of the VTE Core Measure and the nurse s responsibilities

More information

PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB GP REFERRAL FORM 7

PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB GP REFERRAL FORM 7 Guidelines for Primary Care Com mmunity-based Clinicians September 2011 IINDEX PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES... 4 3. WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB

More information

NHS INNOVATION SHOWCASE: DVT DIAGNOSIS AND TREATMENT IN PRIMARY CARE

NHS INNOVATION SHOWCASE: DVT DIAGNOSIS AND TREATMENT IN PRIMARY CARE NHS INNOVATION SHOWCASE: DVT DIAGNOSIS AND TREATMENT IN PRIMARY CARE MARCH 2015 IMPROVING OUTCOMES, SAVING LIVES, SAVING MONEY: INNOVATIVE DVT PATHWAYS www.apptg.org.uk CONTENTS Chair s Foreword: Andrew

More information

Ref: FOI/CAD/ID December Freedom of Information Act 2000

Ref: FOI/CAD/ID December Freedom of Information Act 2000 Ref: FOI/CAD/ID 3663 09 December 2016 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information

More information

Contents. Welcome to the Cath Lab P4/5

Contents. Welcome to the Cath Lab P4/5 Contents Welcome to the Cath Lab Preparation Instructions : information to ensure you are ready for your procedure in the Cath Lab, set out for you as questions (Q) and answers (A) How the day will go

More information

Low Molecular Weight Heparins

Low Molecular Weight Heparins ril 2014 Low Molecular Weight Heparins FINAL CONSOLIDATED COMPREHENSIVE RESEARCH PLAN September 2015 FINALCOMPREHENSIVE RESEARCH PLAN 2 A. Introduction The objective of the drug class review on LMWH is

More information

Aranesp (Darbepoetin) for Renal Anaemia

Aranesp (Darbepoetin) for Renal Anaemia Aranesp (Darbepoetin) for Renal Anaemia Information for patients, relatives and carers Renal Department York and Scarborough Hospitals Tel: 01904 725370 For more information, please contact: Renal Anaemia

More information

Developing Practice for Thrombosis Prevention in Medical Patients at Queens Medical Centre Campus, Nottingham University Hospitals

Developing Practice for Thrombosis Prevention in Medical Patients at Queens Medical Centre Campus, Nottingham University Hospitals Developing Practice for Thrombosis Prevention in Medical Patients at Queens Medical Centre Campus, Nottingham University Hospitals September 2005 - September 2006 Keywords Venous Thromboembolism Thrombosis

More information

Flexible Sigmoidoscopy with an Enema

Flexible Sigmoidoscopy with an Enema Flexible Sigmoidoscopy with an Enema You must read this booklet at least seven days before your test Contents Page What is a flexible sigmoidoscopy? 1 Preparing yourself for a flexible sigmoidoscopy 2

More information

A1. All surgical VTE prevention guidelines are included in the trust policy attached.

A1. All surgical VTE prevention guidelines are included in the trust policy attached. Response sent by email 19 December 2016 St Helier Hospital Wrythe Lane Carshalton Surrey SM5 1AA Tel: 020 8296 2000 Direct dial tel: 020 8296 4992 Re: Freedom of Information request - Ref: FOI 3736 Thank

More information

An Outpatient Program To Treat Deep Venous Thrombosis with Low- Molecular-Weight Heparin

An Outpatient Program To Treat Deep Venous Thrombosis with Low- Molecular-Weight Heparin ORIGINAL ARTICLE STEVEN D. PEARSON, MD, MSc RALPH BLAIR, MD ANDREW HALPERT, MD ERIC EDDY, MPH SYLVIA MCKEAN, MD Harvard Vanguard Medical Associates Department of Ambulatory Care and Prevention Harvard

More information

27 th May 2011 Anticoagulation in Practice. Dr Jennie Wimperis Consultant Haematologist

27 th May 2011 Anticoagulation in Practice. Dr Jennie Wimperis Consultant Haematologist Dr Jennie Wimperis Consultant Haematologist What is Click for Clots? Why we set it up? How we set it up? More details of what it contains Thrombosis Risk Assessment Hospital aquired/associated Thrombosis

More information

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement Shared Care Guideline: Prescribing Agreement Section A: To be completed by the hospital consultant initiating the treatment GP Practice Details: Name: Address: Tel no: Fax no: NHS.net e-mail: Consultant

More information

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names. Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas

More information

Thromboprophylaxis in Adult General Medical Patients - Guidelines for Management

Thromboprophylaxis in Adult General Medical Patients - Guidelines for Management Thromboprophylaxis in Adult General Medical Patients - Guidelines for Management Adapted from the Worcestershire Acute Hospitals NHS Trust Guideline WAHT-MED-010 Version: Provider Quality and Safety Committee

More information

INCLUSION CRITERIA. REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

INCLUSION CRITERIA. REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as Stroke Service in Cerner. ACUTE STROKE CLINICAL PATHWAY The clinical pathway is based on evidence informed practice and is designed to promote timely treatment, enhance quality of care, optimize patient outcomes and support effective

More information

Nursing care plan for anticoagulation therapy

Nursing care plan for anticoagulation therapy Nursing care plan for anticoagulation therapy traditional appointments and walk-in services to on-demand, online care. Island Group Administration, Inc; Providing a Better Plan for Healthcare. Chapter

More information

UW MEDICINE PATIENT EDUCATION. Angiography: Kidney Exam. How to prepare and what to expect. What is angiography? DRAFT. Why do I need this exam?

UW MEDICINE PATIENT EDUCATION. Angiography: Kidney Exam. How to prepare and what to expect. What is angiography? DRAFT. Why do I need this exam? UW MEDICINE PATIENT EDUCATION Angiography: Kidney Exam How to prepare and what to expect This handout explains how to prepare and what to expect when having a kidney exam using angiography. What is angiography?

More information

Fast Facts 2018 Clinical Integration Performance Measures

Fast Facts 2018 Clinical Integration Performance Measures IMPORTANT: LHP providers who do not achieve a minimum CI Score in 2018 will not be eligible for incentive distribution and will be placed on a monitoring plan for the 2019 performance year. For additional

More information

Also available from Huntleigh Healthcare. Patient Information: Pressure ulcers. Venous leg ulcer: A patient carer guide

Also available from Huntleigh Healthcare. Patient Information: Pressure ulcers. Venous leg ulcer: A patient carer guide Also available from Huntleigh Healthcare Patient Information: Pressure ulcers WoundASSIST TNP therapy: A patient information leaflet Venous leg ulcer: A patient carer guide Lympoedema: A patient carer

More information

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

Initiation of Warfarin for patients not registered with Provider Practice

Initiation of Warfarin for patients not registered with Provider Practice Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin

More information

*Your Name *Nursing Facility. radiation therapy. SECTION 2: Acute Change in Condition and Factors that Contributed to the Transfer

*Your Name *Nursing Facility. radiation therapy. SECTION 2: Acute Change in Condition and Factors that Contributed to the Transfer Gaining information about resident transfers is an important goal of the OPTIMISTC project. CMS also requires us to report these data. This form is where data relating to long stay transfers are to be

More information

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9 Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 9 Title of Presentation: OCCG Primary Care Locally Commissioned Services

More information

Inpatient Quality Reporting Program

Inpatient Quality Reporting Program Venous Thromboembolism 2015 Abstraction Guidance Presentation Transcript Moderator: Candace Jackson, RN Inpatient Quality Reporting Support Contract Lead, HSAG Speakers: Denise Krusenoski, MSN, RN, CMSRN,

More information

Clinical Check of Prescriptions in Ward Areas

Clinical Check of Prescriptions in Ward Areas Pharmacy Department Standard Operating Procedures SOP Title Clinical Check of Prescriptions in Ward Areas Author name and Gareth Price designation: Deputy Director of Pharmacy Clinical Services Pharmacy

More information

Ambulatory Emergency Care Pathways. Pulmonary Embolism

Ambulatory Emergency Care Pathways. Pulmonary Embolism Ambulatory Emergency Care Pathways Pulmonary Embolism Effective Date: September 2011 Content Summary Ref Title Description 1 Condition Details Identifies pathway details and clinical sign-off 2 Pathway

More information

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs HEALTH SERVICES RESEARCH FUND HEALTH CARE AND PROMOTION FUND Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

More information

UW MEDICINE PATIENT EDUCATION. Angiography: Percutaneous or Transjugular Liver Biopsy. How to prepare and what to expect. What is a liver biopsy?

UW MEDICINE PATIENT EDUCATION. Angiography: Percutaneous or Transjugular Liver Biopsy. How to prepare and what to expect. What is a liver biopsy? UW MEDICINE PATIENT EDUCATION Angiography: Percutaneous or Transjugular Liver Biopsy How to prepare and what to expect This handout explains how to prepare and what to expect when having a percutaneous

More information

VENOUS THROMBOEMBOLISM POLICY

VENOUS THROMBOEMBOLISM POLICY VENOUS THROMBOEMBOLISM POLICY To be read in conjunction with the DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism) Policy, Admission, Transfer and Discharge Policy and Rapid Tranquilisation Policy

More information

Commissioning effective anticoagulation services for the future: A resource pack for commissioners

Commissioning effective anticoagulation services for the future: A resource pack for commissioners Commissioning effective anticoagulation services for the future: A resource pack for commissioners The development of this commissioning toolkit was supported by Bayer HealthCare. Bayer HealthCare paid

More information

THE PREVENTION AND MANAGEMENT OF VTE IN CARE HOMES:

THE PREVENTION AND MANAGEMENT OF VTE IN CARE HOMES: THE PREVENTION AND MANAGEMENT OF VTE IN CARE HOMES: CURRENT STANDARDS IN ENGLAND DECEMBER 2016 www.apptg.org.uk CONTENTS Chair s Foreword: Andrew Gwynne MP 4 Summary of Findings 5 Introduction 6 Transfer

More information

Expiry Date: January 2009 Template Version: Page 1 of 7

Expiry Date: January 2009 Template Version: Page 1 of 7 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA P A T I E N T I N F O R M A T I O N G U I D E INR Self Testing Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA A Summary INR home testing devices are

More information

Contact sheet e.g SW, CPN, Nursing Home, NOK

Contact sheet e.g SW, CPN, Nursing Home, NOK Date Time Hb Wbc Plts Hct Neuts Na K Urea Creat INR APPT CRP Tot Prot Alb Globulin Bilirubin ALT AlkPhos Gamma Amylase Phoshate Calcium Ca Corr Mag egfr BLOOD RESULTS Adult Major Burns Assessment - Integrated

More information

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016 Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications 1 Introduction Anticoagulants are medicines which slow down the blood clotting process and are used to support the prevention of clot development. They

More information

Integrated Care Pathway Trans Urethral Resection of the Prostate (TURP /GYRUS/HOLAP/HOLEP)

Integrated Care Pathway Trans Urethral Resection of the Prostate (TURP /GYRUS/HOLAP/HOLEP) Integrated Care Pathway Trans Urethral Resection of the Prostate (TURP /GYRUS/HOLAP/HOLEP) Use this pathway for all patients requiring planned surgery for TURP Patient name / Label DOB: Hospital Number

More information

Enhanced Recovery After Surgery (ERAS) Liver Resection Information for patients

Enhanced Recovery After Surgery (ERAS) Liver Resection Information for patients Oxford University Hospitals NHS Trust Enhanced Recovery After Surgery (ERAS) Liver Resection Information for patients What is Enhanced Recovery? Enhanced Recovery is a new way of improving the experience

More information

Survey about Venous Thrombo-Embolism (VTE) Prophylaxis. Nurses

Survey about Venous Thrombo-Embolism (VTE) Prophylaxis. Nurses Survey about Venous Thrombo-Embolism (VTE) Prophylaxis Nurses Dear staff member, This is a short survey about venous thromboembolism (VTE) at your hospital organization. Venous Thromboembolism (VTE) is

More information

Sentinel Stroke National Audit Programme (SSNAP)

Sentinel Stroke National Audit Programme (SSNAP) Sentinel Stroke National Audit Programme (SSNAP) Acute organisational audit report This report is for stroke survivors and their families November 2016 2016 1 Contents Contents... 2 Useful Contacts and

More information

Laparoscopic partial nephrectomy

Laparoscopic partial nephrectomy Laparoscopic partial nephrectomy This leaflet is written to give you information and answer questions you may have about your surgery. If you have any further questions, please speak to your doctor or

More information

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and

More information

Service Specification

Service Specification Service Specification Level 4 Anticoagulation Management Release: Final Date: 1/1/11 Author: Suzanne Pickering Primary Care Commissioning Manager NHS Derbyshire County Owner: Jackie Pendleton Assistant

More information

Reimbursement for Anticoagulation Services

Reimbursement for Anticoagulation Services Journal of Thrombosis and Thrombolysis 12(1), 73 79, 2001. # 2002 Kluwer Academic Publishers, Manufactured in The Netherlands. Reimbursement for Anticoagulation Services Paul W. Radensky McDermott, Will

More information

Azathioprine. Shared Care Agreement for the treatment of Ulcerative colitis and Crohn s disease with Azathioprine, March 2012 Page 1 of 6

Azathioprine. Shared Care Agreement for the treatment of Ulcerative colitis and Crohn s disease with Azathioprine, March 2012 Page 1 of 6 Azathioprine Shared Care Agreement for the treatment of Ulcerative colitis and Crohn s disease with azathioprine, a copy of which must be supplied by the specialist to the GP at commencement, which will

More information

GENERAL CONSENT TO TREAT

GENERAL CONSENT TO TREAT GENERAL CONSENT TO TREAT DATE: PATIENTS NAME: DATE OF BIRTH: MRN: Consent: I request and authorize medical or surgical treatment as may be deemed necessary and appropriate by the physician and his/her

More information

Specialist Surgery Inpatients Breast Reconstruction Surgery Information for patients

Specialist Surgery Inpatients Breast Reconstruction Surgery Information for patients Specialist Surgery Inpatients Breast Reconstruction Surgery Information for patients Your hospital stay This leaflet has been written to give you information about your surgery and what will happen during

More information